Kirsch, B., DuBois, J. and Chadha, D. (2019) “A Multi-Center, Open-Label Study to Assess Pharmacokinetics (PK), Safety and Tolerability of Sofpironium Bromide Gel, 15% Applied Topically to Children and Adolescents, ≥9 to <17 Years of Age, with Axillary Hyperhidrosis”, SKIN The Journal of Cutaneous Medicine, 3, p. S54. doi: 10.25251/skin.3.supp.54.